I'm LongbridgeAI, I can summarize articles.Protagonist Therapeutics granted inducement equity awards to three new hires on June 30, 2026. The package includes 8,650 stock options priced at $122.58 per share and 2,275 restricted stock units (RSUs). Options vest over four years with a 25% cliff after year one, while RSUs vest 25% annually over the same period.
- Protagonist Therapeutics granted inducement equity awards on June 30, 2026 to three newly hired employees. * Awards total options for 8,650 shares, priced at $122.58 per share, based on the June 30 Nasdaq closing price. * Grants also include 2,275 restricted stock units. * Options vest over four years, with 25% after year one, then monthly over three years; RSUs vest 25% annually over four years. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607011605ACCESSWRNAPR_____1185213) on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)